[181 Pages Report] The Spatial Genomics & Transcriptomics Market size was estimated at USD 782.33 million in 2023 and expected to reach USD 879.03 million in 2024, at a CAGR 13.62% to reach USD 1,913.12 million by 2030.
Spatial genomics & transcriptomics is a technique that allows users to obtain gene expression information in a spatial context. This technique has become vital for biomedical research, particularly in developmental biology, cancer, immunology, and neuroscience, to design more effective therapeutics. The rising popularity of spatial analysis in precision medicine has also brought the regulatory and ethical acceptance of genomics and sequencing technologies. However, limited awareness of genomic medicine in developing economies and a shortage of trained medical professionals limit the expansion of spatial techniques. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing are also restraining factors for the market development. Technological advancements in spatial biology primarily focused on artificial intelligence (AI), 3D printing, and standardized diagnostic biomarkers have emerged as a boon for fighting these challenges for the use of spatial genomics and transcriptomics. In the coming years, rising public and private funding for genomics & transcriptomics research is also expected to diversify the use of these technologies in healthcare and life science.
Regional Insights
The Americas has a strong and growing spatial genomics and transcriptomics market, driven by the presence of well-recognized healthcare startups and immense investments for diversifying the product’s R&D portfolio. In October 2022, the Government of Canada announced an investment of over USD 5.6 million for Ontario Genomics to deliver the BioCreate program for helping genomics SMEs in the health, food, and agriculture, and cleantech sectors to bring new products and technologies to market. In the Asia-Pacific region, spatial analysis is used in regenerative medicine drug development scenarios funded by government and biopharma companies. The country’s increased disease burden has been the pillar for the increasing shift to advanced technologies such as spatial genomics and transcriptomics. Owing to the increased concerns associated with ethical acceptance, the use of spatial genomics and transcriptomics is expected to be highly regulated in the Middle East and Africa region. European governments are at the forefront of promoting spatial analysis with government-backed projects introducing new supportive technologies and the rising shift to precision medicine across the economies.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Spatial Genomics & Transcriptomics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Spatial Genomics & Transcriptomics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.
Market Segmentation & Coverage
This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Consumables
- Instruments
- Software
- Technology
- Immunohistochemistry Screening
- Spatial Genomics
- Biochemical Techniques
- Fluorescence in Situ Hybridization
- Genome Perturbation Tools
- Massively-Parallel Sequencing
- Microscopy-Based Live DNA Imaging
- Spatial Transcriptomics
- In Situ Sequencing
- Microtomy Sequencing
- Sequencing-Based Methods
- Transcriptome In-vivo Analysis
- End-Use
- Academic Institutes
- Diagnostic Institutes
- Pharmaceutical Manufacturer
- Translational Research
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Spatial Genomics & Transcriptomics Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Spatial Genomics & Transcriptomics Market?
- What are the technology trends and regulatory frameworks in the Spatial Genomics & Transcriptomics Market?
- What is the market share of the leading vendors in the Spatial Genomics & Transcriptomics Market?
- Which modes and strategic moves are suitable for entering the Spatial Genomics & Transcriptomics Market?
US $
Euro €
GBP £
